BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36463454)

  • 1. BACE2: A Promising Neuroprotective Candidate for Alzheimer's Disease.
    Yeap YJ; Kandiah N; Nizetic D; Lim KL
    J Alzheimers Dis; 2023; 94(s1):S159-S171. PubMed ID: 36463454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes.
    Sun X; Wang Y; Qing H; Christensen MA; Liu Y; Zhou W; Tong Y; Xiao C; Huang Y; Zhang S; Liu X; Song W
    FASEB J; 2005 May; 19(7):739-49. PubMed ID: 15857888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BACE1: the beta-secretase enzyme in Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BACE2 degradation mediated by the macroautophagy-lysosome pathway.
    Liu X; Wang Z; Wu Y; Wang J; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1970-7. PubMed ID: 23773066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome.
    Sun X; He G; Song W
    FASEB J; 2006 Jul; 20(9):1369-76. PubMed ID: 16816112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next Generation Therapeutic Strategy for Treatment and Prevention of Alzheimer's Disease and Aging-Associated Cognitive Decline: Transient, Once-in-a-Lifetime-Only Depletion of Intraneuronal Aβ (
    Volloch V; Rits-Volloch S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BACE1 and BACE2 enzymatic activities in Alzheimer's disease.
    Ahmed RR; Holler CJ; Webb RL; Li F; Beckett TL; Murphy MP
    J Neurochem; 2010 Feb; 112(4):1045-53. PubMed ID: 19968762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Secretase, APP and Abeta in Alzheimer's disease.
    Vassar R
    Subcell Biochem; 2005; 38():79-103. PubMed ID: 15709474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
    Stockley JH; O'Neill C
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BACE2 beyond β-processing of APP, its neuroprotective role in cerebrovascular endothelium.
    Sáez-Valero J; Pérez-González R
    J Neurochem; 2023 Sep; 166(6):887-890. PubMed ID: 37587672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-secretase cleavage at amino acid residue 34 in the amyloid beta peptide is dependent upon gamma-secretase activity.
    Shi XP; Tugusheva K; Bruce JE; Lucka A; Wu GX; Chen-Dodson E; Price E; Li Y; Xu M; Huang Q; Sardana MK; Hazuda DJ
    J Biol Chem; 2003 Jun; 278(23):21286-94. PubMed ID: 12665519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-secretase (BACE) as a drug target for Alzheimer's disease.
    Vassar R
    Adv Drug Deliv Rev; 2002 Dec; 54(12):1589-602. PubMed ID: 12453676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
    Kimura A; Hata S; Suzuki T
    J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer's Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers.
    Huentelman M; De Both M; Jepsen W; Piras IS; Talboom JS; Willeman M; Reiman EM; Hardy J; Myers AJ
    Sci Rep; 2019 Jul; 9(1):9640. PubMed ID: 31270419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.
    Farzan M; Schnitzler CE; Vasilieva N; Leung D; Choe H
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9712-7. PubMed ID: 10931940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BACE2 expression increases in human neurodegenerative disease.
    Holler CJ; Webb RL; Laux AL; Beckett TL; Niedowicz DM; Ahmed RR; Liu Y; Simmons CR; Dowling AL; Spinelli A; Khurgel M; Estus S; Head E; Hersh LB; Murphy MP
    Am J Pathol; 2012 Jan; 180(1):337-50. PubMed ID: 22074738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
    Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
    J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.